Sign in

CIK 0001937993 · <br>Emerging growth company

Cadrenal Therapeutics, Inc.

Sign in to watch
Ticker
CVKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880860746
Phone
904-300-0701
Business address
822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
  1. 8-K Event Executive or director change
  2. D Other Notice of Sales of Unregistered Securities
  3. S-3 Offering Registration Statement
  4. 8-K Event Executive or director change
  5. 4 Planned sale Chairman and CEO sold 7,400 shares at $3.03 ($22,422)
  6. 8-K Event Material agreement · Unregistered share sale · Other events
  7. 8-K Event Executive or director change
  8. 4 Planned sale Chairman, CEO and Interim CFO sold 11,156 shares at an average $3.04 ($33,919)
  9. 4 Planned sale Chairman, CEO and Interim CFO sold 11,444 shares at an average $3.48 ($39,829)
  10. 4 Planned sale Chairman, CEO and Interim CFO sold 4,126 shares at an average $3.18 ($13,110)
  11. 8-K Event Regulation FD disclosure · Other events
  12. 4 Open-market sale Chairman, CEO and Interim CFO sold 18,124 shares at an average $3.88 ($70,352)
  13. 144 Insider Sale of Securities
  14. 4 Planned sale Chairman, CEO and Interim CFO sold 22,385 shares at an average $4.17 ($93,294)
  15. 4 Planned sale CEO and Chairman sold 8,285 shares at an average $4.37 ($36,209)
  16. 8-K Event Executive or director change
  17. 4 Planned sale CEO and Chairman sold 652 shares at an average $4.72 ($3,075)
  18. 4 Planned sale CEO and Chairman sold 12,763 shares at an average $5.44 ($69,451)
  19. 4 Planned sale CEO and Chairman sold 1,165 shares at $5.69 ($6,629)
  20. 144 Insider Sale of Securities

Page 2 of 14 · 277 filings